158 related articles for article (PubMed ID: 3207699)
1. Kinetic properties of the binding of alpha-lytic protease to peptide boronic acids.
Kettner CA; Bone R; Agard DA; Bachovchin WW
Biochemistry; 1988 Oct; 27(20):7682-8. PubMed ID: 3207699
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of specificity: alpha-lytic protease complexes with analogues of reaction intermediates.
Bone R; Frank D; Kettner CA; Agard DA
Biochemistry; 1989 Sep; 28(19):7600-9. PubMed ID: 2611204
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids.
Kettner CA; Shenvi AB
J Biol Chem; 1984 Dec; 259(24):15106-14. PubMed ID: 6392293
[TBL] [Abstract][Full Text] [Related]
4. Boron-11 pure quadrupole resonance investigation of peptide boronic acid inhibitors bound to alpha-lytic protease.
Ivanov D; Bachovchin WW; Redfield AG
Biochemistry; 2002 Feb; 41(5):1587-90. PubMed ID: 11814352
[TBL] [Abstract][Full Text] [Related]
5. Interaction of peptide boronic acids with elastase: circular dichroism studies.
Berry SC; Fink AL; Shenvi AB; Kettner CA
Proteins; 1988; 4(3):205-10. PubMed ID: 3237718
[TBL] [Abstract][Full Text] [Related]
6. 11B NMR spectroscopy of peptide boronic acid inhibitor complexes of alpha-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes.
Tsilikounas E; Kettner CA; Bachovchin WW
Biochemistry; 1993 Nov; 32(47):12651-5. PubMed ID: 8251483
[TBL] [Abstract][Full Text] [Related]
7. Nitrogen-15 NMR spectroscopy of the catalytic-triad histidine of a serine protease in peptide boronic acid inhibitor complexes.
Bachovchin WW; Wong WY; Farr-Jones S; Shenvi AB; Kettner CA
Biochemistry; 1988 Oct; 27(20):7689-97. PubMed ID: 3207700
[TBL] [Abstract][Full Text] [Related]
8. New inhibitors of thrombin and other trypsin-like proteases: hydrogen bonding of an aromatic cyano group with a backbone amide of the P1 binding site replaces binding of a basic side chain.
Lee SL; Alexander RS; Smallwood A; Trievel R; Mersinger L; Weber PC; Kettner C
Biochemistry; 1997 Oct; 36(43):13180-6. PubMed ID: 9341205
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of fluoroketone inhibitors of alpha-lytic protease and human leukocyte elastase.
Govardhan CP; Abeles RH
Arch Biochem Biophys; 1990 Jul; 280(1):137-46. PubMed ID: 2353815
[TBL] [Abstract][Full Text] [Related]
10. Identification of serine and histidine adducts in complexes of trypsin and trypsinogen with peptide and nonpeptide boronic acid inhibitors by 1H NMR spectroscopy.
Tsilikounas E; Kettner CA; Bachovchin WW
Biochemistry; 1992 Dec; 31(51):12839-46. PubMed ID: 1463754
[TBL] [Abstract][Full Text] [Related]
11. Active site of alpha-lytic protease: enzyme-substrate interactions.
Bauer CA; Brayer GD; Sielecki AR; James MN
Eur J Biochem; 1981 Nov; 120(2):289-94. PubMed ID: 7032913
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of serine proteases by peptidyl fluoromethyl ketones.
Imperiali B; Abeles RH
Biochemistry; 1986 Jul; 25(13):3760-7. PubMed ID: 3527255
[TBL] [Abstract][Full Text] [Related]
13. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
Oleksyszyn J; Powers JC
Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
[TBL] [Abstract][Full Text] [Related]
15. Peptide boronic acids, substrate analogs, inhibit chymase, and histamine release from rat mast cells.
Kato Y; Kido H; Fukusen N; Katunuma N
J Biochem; 1988 May; 103(5):820-2. PubMed ID: 2460436
[TBL] [Abstract][Full Text] [Related]
16. Induction and exacerbation of emphysema in hamsters with human neutrophil elastase inactivated reversibly by a peptide boronic acid.
Stone PJ; Lucey EC; Snider GL
Am Rev Respir Dis; 1990 Jan; 141(1):47-52. PubMed ID: 2297186
[TBL] [Abstract][Full Text] [Related]
17. Relationship between enzyme specificity and the backbone dynamics of free and inhibited alpha-lytic protease.
Davis JH; Agard DA
Biochemistry; 1998 May; 37(21):7696-707. PubMed ID: 9601029
[TBL] [Abstract][Full Text] [Related]
18. Kinetic characterization and inhibition of the rat MAB elastase-2, an angiotensin I-converting serine protease.
Santos CF; Paula CA; Salgado MC; Oliveira EB
Can J Physiol Pharmacol; 2002 Jan; 80(1):42-7. PubMed ID: 11911225
[TBL] [Abstract][Full Text] [Related]
19. Acylamino boronic acids and difluoroborane analogues of amino acids: potent inhibitors of chymotrypsin and elastase.
Kinder DH; Katzenellenbogen JA
J Med Chem; 1985 Dec; 28(12):1917-25. PubMed ID: 3851848
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a new serine proteinase from Bacillus subtilis with specificity for amino acids at P1 and P2 positions.
Yamagata A; Yoshida N; Noda K; Ito A
Biochim Biophys Acta; 1995 Dec; 1253(2):224-8. PubMed ID: 8519806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
